Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer. Matsuo K, Shimada M, Matsuzaki S, Machida H, et al. Int J Gynecol Cancer 2024 Aug 6:ijgc-2024-005597. doi: 10.1136/ijgc-2024-005597.

Read + Share

Amedeo Smart

Independent Medical Education

Matsuo K, Shimada M, Matsuzaki S, Machida H, et al. Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer. Int J Gynecol Cancer 2024 Aug 6:ijgc-2024-005597. doi: 10.1136/ijgc-2024-005597.
PMID: 39107048